Associate Sponsors

Co-sponsor

Home / India News / Ranbaxy to manufacture and market Fenofibrate Capsules USP 43 mg and 130 mg

Ranbaxy to manufacture and market Fenofibrate Capsules USP 43 mg and 130 mg

Image
Capital Market
Last Updated : Nov 05 2014 | 9:38 PM IST
LinkedIN IconFacebook Icon

After USFDA approval

Ranbaxy Laboratories announced that the Company has received approval from the USFDA to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg.

Powered by Capital Market - Live News

Connect with us on WhatsApp

More From This Section

Panacea Biotec announces appointment of director

Nivyah Infrastructure & Telecom Services announces shifting of corporate office

Ambuja Cements allots equity shares

ICICI Bank allots equity shares

First Published: Nov 05 2014 | 4:05 PM IST

Explore News

Next Story